Mallinckrodt

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.

Mallinckrodt doses first patient in muscular dystrophy trial

Repurposed drug could help delay decline in muscle function. Mallinckrodt has kicked off a phase II trial of its Duchenne muscular dystrophy candidate, a repurposed drug used for years for inflammatory ... Mallinckrodt’s step forward comes shortly

Deal Watch January 2018

Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International. RECOTHROM Thrombin topical and PREVELEAK Surgical Sealant to control bleeding in surgery.

Mallinckrodt pays $1.2bn for Sucampo Pharma

As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Mallinckrodt is paying $18 per share for Sucampo and will also assume the company’s $360m debt under the terms of

Pharma deals continue to slide

products. While this may not have been the reason behind GSK’s termination of its rare disease projects, it has not deterred Mallinckrodt from acquiring Infacare, a US company with a ... 469 (upfront 31). Infacare (US). Mallinckrodt (US/GB). Company

Deal Watch August 2016

Mallinckrodt (US) Nuclear Imaging business. IBA Molecular (BE). Asset acquisition. Diagnostic imaging products for use in nuclear medicine including molybdenum-99.

1 2 3 4 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology